The real-world outcomes of multiple myeloma patients treated with daratumumab

Most patients cannot be included in randomized clinical trials. We report real-world outcomes of all Danish patients with multiple myeloma (MM) treated with daratumumab-based regimens until 1 January 2019. METHODS: Information of 635 patients treated with daratumumab was collected retrospectively an...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabo, Agoston Gyula, Klausen, Tobias Wirenfeldt, Levring, Mette Bøegh, Preiss, Birgitte, Helleberg, Carsten, Breinholt, Marie Fredslund, Hermansen, Emil, Gjerdrum, Lise Mette Rahbek, Bønløkke, Søren Thorgaard, Nielsen, Katrine, Kjeldsen, Eigil, Iversen, Katrine Fladeland, Teodorescu, Elena Manuela, Dokhi, Marveh, Kurt, Eva, Strandholdt, Casper, Andersen, Mette Klarskov, Vangsted, Annette Juul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2021
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513840/
https://www.ncbi.nlm.nih.gov/pubmed/34644367
http://dx.doi.org/10.1371/journal.pone.0258487

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8513840/
https://www.ncbi.nlm.nih.gov/pubmed/34644367
http://dx.doi.org/10.1371/journal.pone.0258487

Ejemplares similares